0%

est. 2Y upside i

CybersecuritySeries B

Rank

#2040

Sector

Cybersecurity

Est. Liquidity

~0Y

Data Quality

Data: Low

Capsule8 was acquired in 2021 by Sophos, making it a private subsidiary.

Last updated: July 21, 2026

Bull (15%)0%

Company acquired by Sophos in 2021; no independent upside for new equity. Hypothetical bull would require acquisition price > entry valuation, but no data.

Base (55%)0%

Post-acquisition, equity value is fixed at acquisition price; unknown if above entry. Base case assumes zero upside from entry.

Bear (30%)-100%

If acquisition price was below total funding ($30M) or entry valuation, common stock could be worthless; preference stack wipes out common.

Est. time to liquidity~0.0 years

Preference Stack Risk

high

Funding Intensity

3000%

Total funding $30M with unknown valuation; preference stack likely exceeds common equity value if acquisition price is low.

Dilution Risk

high

No recent funding round; potential dilution if Sophos issues additional equity or if there are grants from a new plan.

Secondary Liquidity

none

No secondary market for private shares of acquired subsidiary.

Other — 25 roles

View all 25 open roles at Capsule8 →

Last updated: September 6, 2026

Questions to Ask at the Interview

Strategic questions based on Capsule8's data — designed to show you've done your homework.

  • 1

    “How has the integration with Sophos affected the product roadmap and go-to-market strategy?”

  • 2

    “What is the current ARR and growth rate of the Capsule8 business within Sophos?”

  • 3

    “What is the employee equity plan: Is it restricted stock in Sophos, and what liquidity events are anticipated?”

Community

Valuation Sentiment

Our model estimates 0% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.